PNPLA3 and Hepatic fibrosis: Researchers have also discovered that treating mice with antisense oligonucleotides targeting the PNPLA3 gene suppressed the expression of the PNPLA3 I148M variant, slowed the progression of NAFLD, and improved liver fibrosis [24].